Authors
Latest:
Study Underscores Need for More Effective Psoriasis Oral TherapiesSurvey responses revealed the rates and times at which patients switched from oral to biologic therapies.
Latest:
Data Support the Use of First-/Second-Line Immune Checkpoint Inhibitors in HNSCCFindings from a retrospective cohort study found that immune checkpoint inhibitors induced promising responses in the first- and second-line treatment of head and neck squamous cell carcinoma.
Latest:
Dermatologist Talks About the ABCs of Wounds and HS Support at Annual MeetingExpert insights on the latest issues in wounds as well as HS resources are shared at the annual meeting.
Latest:
Holistic Aesthetics Center to Host First Annual Symposium in Middletown, New YorkJeffrey Yager, MD, discusses the new SY Aesthetics campus that will integrate traditional and Chinese healing.
Latest:
Frontline Forum Part 4: Solutions in the Management and Treatment of Basal Cell CarcinomaIn part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.
Latest:
Novel, Nonsurgical BCC Treatment Shown Safe and EffectiveIn this study, researchers treated 37 basal cell carcinoma (BCC) lesions from 30 patients, with follow-ups at 5 time points after baseline examination.
Latest:
Experts Warn Climate Change May Lead to More Childhood Psoriasis CasesThe increasing prevalence of this chronic condition in children necessitates understanding its broader impacts and management strategies.
Latest:
The Crystal Ball: What This Means for the Future of Atopic Dermatitis TreatmentsPeter Lio, MD, reflects on current unmet needs in atopic dermatitis and suggests directions for future research and development.
Latest:
Anna López-Ferrer, MD, PhD, and Volker Koscielny, MD, MBA, Share Highlights From Almirall’s 15th Skin AcademyLópez-Ferrer discussed how to achieve well-being for patients with psoriasis and Koscielny discussed the unique topics of the Skin Academy.
Latest:
The Many Considerations of Managing Generalized Pustular PsoriasisExperts discuss the treatment landscape of generalized pustular psoriasis as well as review difficult cases of GPP.
Latest:
When to Call a Time Out on Mohs SurgeryJerry Brewer, MD, MS, shared pearls on reasons to avoid or discontinue Mohs surgery and keeping calm with stressed, vulnerable patients.
Latest:
Looking Ahead to the Future of DermatologyAs SDPA summer sessions have concluded, Arash Mostaghimi, MD, MPA, MPH, delves into what lies ahead in the dermatology industry—including the importance of collaboration between physicians and PAs.
Latest:
Award-Winning Research on Hair Loss Consensus Highlighted at Annual MeetingThe poster, which shares results form consensus research on using LODM for hair loss, was awarded 4th place at the 2024 AAD Annual Meeting.
Latest:
3 Approaches to Creating a Connected Care FutureBy integrating capabilities and services, we can create health experiences that are much more than the sum of their parts.
Latest:
Severe Hemorrhage from Infantile HemangiomaA 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
Latest:
Understanding Clascoterone Cream: MOA, Patient Selection Criteria, and Gender-Inclusive AdvantagesContinuing the discussion on the case of a 17-year-old patient with moderate acne, Heather Woolery-Lloyd, MD, FAAD, provides an overview of the utilization of clascoterone cream, highlighting the application process and its unique mechanism of action.
Latest:
The Adalimumab Biosimiliar Pipeline: What's AheadFDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Latest:
Take-home Points to Manage AcneDrs Joshua Zeichner, MD, and Mona Gohara, MD, provide take-home messages to providers treating patients with acne.
Latest:
Shingles Vaccination Counseling During the COVID-19 PandemicCDC advises not to delay shingles vaccination.
Latest:
Katie Martin, PA-C, Share Insights Into Aesthetic Innovations in 2023 and What’s to Come in 2024The approval of Galderma’s Restylane Eyelight was one of Martin’s top highlights of 2023.
Latest:
Parents Worries About Severe Acne’s Impact on TeensMore than 90% of respondents to a recent survey expressed concern about acne’s effect on their adolescent’s mental health and social life.
Latest:
Severe Hemorrhage from Infantile HemangiomaA 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
Latest:
What You Don’t Know and Should Know About PasswordsJ.D. Norcross, director of information technology at VitalSkin Dermatology, discusses some myths and best practices with digital passwords you should know to help keep your practice information safer.
Latest:
Practice Management Pearls From ACAAI: Tips for Going GreenTodd L. Sack, MD, shares practice management tips for going green at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.
Latest:
FDA Approves Relatlimab Plus Nivolumab for Unresectable or Metastatic MelanomaThe FDA has approved the fixed-dose combination of relatlimab plus nivolumab for the treatment of adult and pediatric patients who are 12 years of age or older and who have unresectable or metastatic melanoma.
